These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 3706572

  • 1. Osmotic blood-brain barrier opening to IgM monoclonal antibody in the rat.
    Neuwelt EA, Minna J, Frenkel E, Barnett PA, McCormick CI.
    Am J Physiol; 1986 May; 250(5 Pt 2):R875-83. PubMed ID: 3706572
    [Abstract] [Full Text] [Related]

  • 2. Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragments to normal brain utilizing osmotic blood-brain barrier disruption.
    Neuwelt EA, Barnett PA, Hellström I, Hellström KE, Beaumier P, McCormick CI, Weigel RM.
    Cancer Res; 1988 Sep 01; 48(17):4725-9. PubMed ID: 3409213
    [Abstract] [Full Text] [Related]

  • 3. Comparison of various methods for delivering radiolabeled monoclonal antibody to normal rat brain.
    Bullard DE, Bourdon M, Bigner DD.
    J Neurosurg; 1984 Nov 01; 61(5):901-11. PubMed ID: 6436447
    [Abstract] [Full Text] [Related]

  • 4. Osmotic opening of the blood-brain barrier to methotrexate in the rat.
    Ohno K, Fredericks WR, Rapoport SI.
    Surg Neurol; 1979 Oct 01; 12(4):323-8. PubMed ID: 524251
    [Abstract] [Full Text] [Related]

  • 5. Delivery of human interferon-alpha to brain by transient osmotic blood-brain barrier modification in the rat.
    Greig NH, Fredericks WR, Holloway HW, Soncrant TT, Rapoport SI.
    J Pharmacol Exp Ther; 1988 May 01; 245(2):581-6. PubMed ID: 3367308
    [Abstract] [Full Text] [Related]

  • 6. A Distinct Advantage to Intraarterial Delivery of 89Zr-Bevacizumab in PET Imaging of Mice With and Without Osmotic Opening of the Blood-Brain Barrier.
    Lesniak WG, Chu C, Jablonska A, Du Y, Pomper MG, Walczak P, Janowski M.
    J Nucl Med; 2019 May 01; 60(5):617-622. PubMed ID: 30315146
    [Abstract] [Full Text] [Related]

  • 7. Increased delivery of tumor-specific monoclonal antibodies to brain after osmotic blood-brain barrier modification in patients with melanoma metastatic to the central nervous system.
    Neuwelt EA, Specht HD, Barnett PA, Dahlborg SA, Miley A, Larson SM, Brown P, Eckerman KF, Hellström KE, Hellström I.
    Neurosurgery; 1987 Jun 01; 20(6):885-95. PubMed ID: 3112602
    [Abstract] [Full Text] [Related]

  • 8. In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans.
    Siegal T, Rubinstein R, Bokstein F, Schwartz A, Lossos A, Shalom E, Chisin R, Gomori JM.
    J Neurosurg; 2000 Apr 01; 92(4):599-605. PubMed ID: 10761648
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH, Chen YF, Chen FD, Hwang JJ, Chen JC, Liu RS, Kai JJ, Chang CW, Wang HE.
    J Nucl Med; 2005 Nov 01; 46(11):1858-65. PubMed ID: 16269600
    [Abstract] [Full Text] [Related]

  • 10. Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae.
    Spigelman MK, Zappulla RA, Strauchen JA, Feuer EJ, Johnson J, Goldsmith SJ, Malis LI, Holland JF.
    Cancer Res; 1986 Mar 01; 46(3):1453-7. PubMed ID: 3510725
    [Abstract] [Full Text] [Related]

  • 11. Differential blood-brain barrier permeabilities to [14C]sucrose and [3H]inulin after osmotic opening in the rat.
    Ziylan YZ, Robinson PJ, Rapoport SI.
    Exp Neurol; 1983 Mar 01; 79(3):845-57. PubMed ID: 6825767
    [Abstract] [Full Text] [Related]

  • 12. The effects of the Na(+)/Ca(++) exchange blocker on osmotic blood-brain barrier disruption.
    Bhattacharjee AK, Nagashima T, Kondoh T, Tamaki N.
    Brain Res; 2001 May 11; 900(2):157-62. PubMed ID: 11334793
    [Abstract] [Full Text] [Related]

  • 13. Osmotic blood-brain barrier modification: monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain.
    Neuwelt EA, Barnett PA, McCormick CI, Frenkel EP, Minna JD.
    Neurosurgery; 1985 Sep 11; 17(3):419-23. PubMed ID: 3930991
    [Abstract] [Full Text] [Related]

  • 14. Blood-brain barrier permeability to sucrose and dextran after osmotic opening.
    Ziylan YZ, Robinson PJ, Rapoport SI.
    Am J Physiol; 1984 Oct 11; 247(4 Pt 2):R634-8. PubMed ID: 6208789
    [Abstract] [Full Text] [Related]

  • 15. Quantitative aspects of reversible osmotic opening of the blood-brain barrier.
    Rapoport SI, Fredericks WR, Ohno K, Pettigrew KD.
    Am J Physiol; 1980 May 11; 238(5):R421-31. PubMed ID: 7377381
    [Abstract] [Full Text] [Related]

  • 16. Bilirubin-induced changes in brain energy metabolism after osmotic opening of the blood-brain barrier.
    Wennberg RP, Johansson BB, Folbergrová J, Siesjö BK.
    Pediatr Res; 1991 Nov 11; 30(5):473-8. PubMed ID: 1754304
    [Abstract] [Full Text] [Related]

  • 17. Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats.
    Zhang J, Takahashi HK, Liu K, Wake H, Liu R, Maruo T, Date I, Yoshino T, Ohtsuka A, Mori S, Nishibori M.
    Stroke; 2011 May 11; 42(5):1420-8. PubMed ID: 21474801
    [Abstract] [Full Text] [Related]

  • 18. A narrow time-window for access to the brain by exogenous protein after immunological targeting of a blood-brain barrier antigen.
    N Ghabriel M, J Lu J, Tadros R, Hermanis G.
    J Comp Pathol; 2004 Jul 11; 131(1):52-60. PubMed ID: 15144799
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
    Shapiro WR, Voorhies RM, Hiesiger EM, Sher PB, Basler GA, Lipschutz LE.
    Cancer Res; 1988 Feb 01; 48(3):694-701. PubMed ID: 3335031
    [Abstract] [Full Text] [Related]

  • 20. Quantification of early blood-brain barrier disruption by in situ brain perfusion technique.
    Bhattacharjee AK, Nagashima T, Kondoh T, Tamaki N.
    Brain Res Brain Res Protoc; 2001 Oct 01; 8(2):126-31. PubMed ID: 11673094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.